Antimicrobial composition
AssigneeBlis Technologies Limited
InventorsChristopher Norman Chilcott, John Robert Tagg
Life of this patent
Estimating the term…
Abstract
This invention provides novel Streptococcus salivarius, compositions containing same, and use of S. salivarius strains as antimicrobial agents. The strains are bacterial inhibitors with respect to at least S. mutans and/or MS and therefore have a number of therapeutic applications. The applications include but are not limited to forming part of therapeutic formulations for use in controlling, treating, or preventing dental caries.
Claims25
A biologically pure culture of Streptococcus salivarius strain Mia on deposit at Deutsche Samrnlung von Mikroorganismen Und Zeilkulturen GmbH, Mascheroder Weg 1 b, D-38124, Braunschweig, Germany, Accession No. DSM 14685.
An antibacterial composition comprising a biologically pure culture of Streptococcus salivarius strain Mia on deposit at Deutsche Sanimlung von Mikroorganismen Und Zellkulturen GmbH, Mascheroder Weg 1 b, D-38124, Braunschweig, Germany, Accession No. DSM 14685.
A method for inhibiting in the oral cavity of an individual the growth of bacteria sensitive to Streptococcus salivarius strain Mia on deposit at Deutsche Sammlung von Mikroorganismen Und Zellkulturen GmbH, MascheroderWeg 1b, D-38124, Braunschweig, Germany, Accession No. DSM 14685, the method comprising pre-treating the individual with an effective amount of an antimicrobial or antibiotic to reduce the microflora already present and administering to the oral cavity of the individual an inhibitory effective amount of said S. salivarius strain Mia.
Dependencies are inferred from the claim text.